Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$20.6 - $37.15 $362,724 - $654,137
-17,608 Closed
0 $0
Q2 2018

Nov 08, 2023

SELL
$14.15 - $20.75 $473,331 - $694,108
-33,451 Reduced 65.51%
17,608 $365,000
Q2 2018

Aug 14, 2018

SELL
$14.15 - $20.75 $473,331 - $694,108
-33,451 Reduced 65.51%
17,608 $365,000
Q1 2018

Nov 08, 2023

BUY
$13.0 - $15.8 $663,767 - $806,732
51,059 New
51,059 $735 Million
Q4 2017

Nov 08, 2023

BUY
$10.0 - $15.7 $510,590 - $801,626
51,059 New
51,059 $774 Million
Q4 2017

Feb 12, 2018

BUY
$10.0 - $15.7 $510,590 - $801,626
51,059
51,059 $774,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $679M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.